Secondary Market for Anthropic Shares Heats Up Raising Fraud Concerns GD Holdings Acquires 16 St Regis Chicago Condos from Sony in 21M Transaction Dow Leads as Defensive Sectors Outperform Tech Lags Fraudsters Fake Ancient Statues Foiled by Bogus Paperwork at Sothebys Crossroads Capital Investments Bet on Nebius Group NBIS Gains Traction Bhatia Communications Shares Rise 3 on Strong Q4 FY26 Earnings Dividend Announcement Amid Market Selloff ATER Q3 2025 Earnings EPS Surpasses Estimates by Over 56 Stock Rises Diana Shipping DSX Q1 2026 Earnings EPS Surprises to the Upside Shares Decline AHT Earnings Overview 20260528 Viavi Solutions VIAV Q1 2026 Earnings EPS Surges Past Estimates as Shares Rise Lineage Cell Therapeutics Q1 2026 Earnings WiderthanExpected Loss as ClinicalStage Biotech Continues Pipeline Investment RVTY Q1 2026 Earnings EPS Surpasses Estimates Amid Flat Stock Reaction Damora Therapeutics DMRA Gains 24 as Biotech Sector Finds Footing Tilray Brands TLRY Slips 3 as Cannabis Stock Tests Key Support Levels Park National Corporation Holds Steady as Support Levels Provide a Foundation Odyssey Marine Exploration OMEX Holds Near Support After Modest Daily Gain Whats Next Eaton Vance TaxManaged Diversified Equity Income Fund ETY Edges Higher Amid Cautious Trading Fed Holds Rates Steady Amid Highest Level of Dissent Since 1992 Movado Group Q1 2026 Earnings Massive EPS Beat Drives Stock Higher Heartcore Enterprises Inc HTCR Surges 124 Breaking Above Key Support Levels Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development ConocoPhillips Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower NLY Q1 2026 Earnings Slight EPS Beat Amid Uncertain Rate Environment and Modest Stock Decline Once Upon a Farm PBC OFRM Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Uncertainty GXO Logistics Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain ATNM Q1 2026 Earnings Actinium Reports NarrowerThanExpected Loss as Pipeline Progress Continues ORMP Q4 2025 Earnings Surprise Profit Beats Zero Estimate as Biotech Advances Pipeline